z-logo
open-access-imgOpen Access
The regulation of cognitive enhancement devices: extending the medical model
Author(s) -
Hannah Maslen,
Thomas Douglas,
Roi Cohen Kadosh,
Neil Levy,
Julian Savulescu
Publication year - 2014
Publication title -
journal of law and the biosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 18
ISSN - 2053-9711
DOI - 10.1093/jlb/lst003
Subject(s) - cognition , risk analysis (engineering) , arbitrariness , computer science , function (biology) , legislation , product (mathematics) , medical device , business , medicine , neuroscience , psychology , law , political science , linguistics , philosophy , geometry , mathematics , evolutionary biology , biomedical engineering , biology
This article presents a model for regulating cognitive enhancement devices (CEDs). Recently, it has become very easy for individuals to purchase devices which directly modulate brain function. For example, transcranial direct current stimulators are increasingly being produced and marketed online as devices for cognitive enhancement. Despite posing risks in a similar way to medical devices, devices that do not make any therapeutic claims do not have to meet anything more than basic product safety standards. We present the case for extending existing medical device legislation to cover CEDs. Medical devices and CEDs operate by the same or similar mechanisms and pose the same or similar risks. This fact coupled with the arbitrariness of the line between treatment and enhancement count in favour of regulating these devices in the same way. In arguing for this regulatory model, the paper highlights potential challenges to its implementation, and suggests solutions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom